prednisone has been researched along with Glomerulonephritis, Minimal Change in 159 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cyclosporine (CsA) is effective in treating steroid-dependent (SDNS) and steroid-resistant (SRNS) nephrotic syndrome (NS) in children, but because of the potential for chronic nephrotoxicity, its long-term use is controversial." | 9.08 | Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. ( Bunchman, TE; Gregory, MJ; Johnson, K; Kershaw, DB; Sedman, A; Smoyer, WE; Valentini, RP, 1996) |
| "Twenty-eight patients with an onset of nephrotic syndrome within 1 year were randomized to receive either ciclosporin and low-dose prednisone or high-dose prednisone alone." | 9.07 | A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. ( Pomrantz, A; Suthanthiran, M; Tejani, A, 1991) |
| "Thirteen adult patients with nephrotic syndrome resistant to corticosteroid administration were treated with azathioprine daily for four years." | 7.67 | Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. ( Cade, R; Campbell, K; Croker, B; Mars, D; Peterson, J; Privette, M; Thompson, R, 1986) |
| "Mechlorethamine has been assessed in 28 patients with idiopathic nephrotic syndrome previously treated with prednisone only." | 7.67 | [Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood]. ( Canals, MJ; Cervera, A; Gómez Campderá, FJ; Gómez Campderá, J; López Gómez, JM; Luque, A; Morales, JL, 1984) |
| "Cyclosporine (CsA) is effective in treating steroid-dependent (SDNS) and steroid-resistant (SRNS) nephrotic syndrome (NS) in children, but because of the potential for chronic nephrotoxicity, its long-term use is controversial." | 5.08 | Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis. ( Bunchman, TE; Gregory, MJ; Johnson, K; Kershaw, DB; Sedman, A; Smoyer, WE; Valentini, RP, 1996) |
| "Twenty-eight patients with an onset of nephrotic syndrome within 1 year were randomized to receive either ciclosporin and low-dose prednisone or high-dose prednisone alone." | 5.07 | A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children. ( Pomrantz, A; Suthanthiran, M; Tejani, A, 1991) |
| " For instance, in patients with idiopathic membranous glomerulonephritis a six months treatment with chlorambucil (0." | 5.05 | [Drug treatment of chronic glomerulonephritis: pro]. ( Brodehl, J; Helmchen, U; Koch, KM; Kühn, K, 1985) |
| "Normally, Kimura disease-associated nephrotic syndrome patients are sensitive to prednisone therapy but are likely to relapse." | 4.85 | Kimura disease: a case report and review of the Chinese literature. ( Chen, YF; Gu, WZ; Liu, AM; Mao, JH; Wang, DY; Zhang, Y; Zhao, SA, 2009) |
| "Prednisone monotherapy is the treatment of choice for patients with a nephrotic syndrome due to minimal change glomerulopathy." | 4.80 | [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy]. ( Branten, AJ; Wetzels, JF, 1998) |
| "This investigation is an assessment of the cyclosporin A-prednisone treatment which has been employed in all cases of therapy-resistant nephrotic syndrome in adults (n = 18) since January 1985 at the Department of Nephrology at the State University Hospital." | 3.68 | [Cyclosporin A treatment of adult patients with severe nephrotic syndrome]. ( Nyrop, M; Olgaard, K, 1992) |
| "Response to initial course of prednisone and clinical outcome were reviewed in 82 children with nephrotic syndrome (NS) due to minimal change disease (MCD) and 2 variants of mesangial proliferative glomerulonephritis (MesPGN)." | 3.67 | Clinical features and glomerular immunofluorescence of renal biopsies from children with nephrotic syndrome due to minimal change disease and two variants of mesangial proliferative glomerulonephritis. ( Baumal, R; Hui, A; Poucell, S; Rance, CP; Thorner, P, 1984) |
| "Mechlorethamine has been assessed in 28 patients with idiopathic nephrotic syndrome previously treated with prednisone only." | 3.67 | [Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood]. ( Canals, MJ; Cervera, A; Gómez Campderá, FJ; Gómez Campderá, J; López Gómez, JM; Luque, A; Morales, JL, 1984) |
| "Thirteen adult patients with nephrotic syndrome resistant to corticosteroid administration were treated with azathioprine daily for four years." | 3.67 | Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids. ( Cade, R; Campbell, K; Croker, B; Mars, D; Peterson, J; Privette, M; Thompson, R, 1986) |
| "Pediatric patients (4-12 years of age) with minimal change nephropathy were consecutively assigned to receive prednisone monotherapy (1-2 mg/kg/d; maximal total dose, ≤60 mg) or prednisone at the same dosage plus fluvastatin (5 mg/d if aged <5 years; 10 mg/d if aged ≥5 years), for 6 weeks." | 2.78 | Effects of combined prednisone + fluvastatin on cholesterol and bilirubin in pediatric patients with minimal change nephropathy. ( Gong, J; Li, A; Ma, L; Song, M; Xie, Y; Yan, Y; Yang, D; Zhou, X, 2013) |
| "73 m(2) for a total dosage of 10 g/1." | 2.77 | Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial. ( Chen, J; Li, H; Li, X; Shen, H; Shi, X; Wang, H; Xu, G, 2012) |
| "Membranous nephropathy, focal segmental glomerulosclerosis (FSGS), and minimal change disease (MCD) are the most common causes of idiopathic nephrotic syndrome." | 2.50 | B cell suppression in primary glomerular disease. ( Deegens, JK; Hofstra, JM; Rood, IM; Wetzels, JF, 2014) |
| "The pathogenesis of minimal change disease (MCD), considered to be the simplest form of nephrotic syndrome, has been one of the major unsolved mysteries in kidney disease." | 2.48 | New insights into human minimal change disease: lessons from animal models. ( Chugh, SS; Clement, LC; Macé, C, 2012) |
| " In case of steroid responsiveness, the risk is the relapse when the steroid dosage is tapered or stopped and the complications related to the treatment which is given to maintain remission." | 2.42 | [Lipoid nephrosis in childhood]. ( Niaudet, P, 2003) |
| " Therefore, intravenous high-dose steroid pulses, alternate-day prednisone, short courses with cytotoxic agents and long-term administration of azathioprine have been suggested as alternatives to the classical prolonged corticotherapy." | 2.38 | Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults. ( Passerini, P; Ponticelli, C, 1991) |
| "There is no definite treatment for focal glomerulosclerosis." | 2.38 | Treatment of the nephrotic syndrome with cyclosporin A. ( Ponticelli, C, 1992) |
| " The primary outcome was to evaluate cumulative prednisone dosage at 12 and 24 months of follow-up in the two groups." | 1.91 | Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice. ( Emma, F; Gatto, A; Gianviti, A; Lucchetti, L; Massella, L; Vivarelli, M, 2023) |
| "In adults with minimal change disease (MCD), only circulating plasmablasts are increased during the active phase of the disease, among B cell subsets." | 1.72 | Circulating plasmablasts in children with steroid-sensitive nephrotic syndrome. ( Carsetti, R; Cascioli, S; Colucci, M; Emma, F; Vivarelli, M; Zotta, F, 2022) |
| " In the past, attempts to reduce the dosage of glucocorticoids were made using cyclophosphamide, cyclosporin A, mofetil mycophenolate, and their combinations." | 1.72 | [Efficacy of rituximab in minimal change disease, an atypical renal manifestation of antiphospholipid syndrome]. ( Długosz, G; Masajtis-Zagajewska, A; Nowicki, M, 2022) |
| "We report on the development of minimal change disease (MCD) with nephrotic syndrome and acute kidney injury (AKI), shortly after first injection of the BNT162b2 COVID-19 vaccine (Pfizer-BioNTech)." | 1.62 | Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine. ( Fytlovich, S; Lebedev, L; Levin-Iaina, N; Sapojnikov, M; Tobar, A; Varadi-Levi, R; Wechsler, A; Yagil, Y; Zamir, D, 2021) |
| "0 mg/kg/day and continued for 4-6 weeks and (2) dosage was reduced to 0." | 1.51 | Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease. ( Ando, M; Arima, H; Hagiwara, D; Hayashi, H; Kato, S; Katsuno, T; Maruyama, S; Ozeki, T; Tsuboi, N; Yasuda, Y, 2019) |
| "Three relapses were successfully retreated with rituximab again, after induction therapy with 60 mg prednisone per day." | 1.42 | A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood. ( Betjes, MG; Dekkers, MJ; Groothoff, JW; Zietse, R, 2015) |
| "Among these abnormalities, minimal change nephrotic syndrome (MCNS) is the most common." | 1.42 | The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome. ( Dinçel, N; Hacıkara, Ş; Kaplan Bulut, İ; Mir, S; Yılmaz, E, 2015) |
| "Minimal change nephrotic syndrome is the most frequent cause of nephrotic syndrome in childhood." | 1.40 | Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms. ( Chen, J; Chen, X; Dong, H; Fu, Y; Guo, J; He, F; Hu, H; Huang, L; Liao, L; Lu, J; Ma, Y; Tan, J; Wang, J; Wu, W; Wu, Z; Xu, Z; Yang, S; Zheng, F; Zou, Y, 2014) |
| "New onset minimal change disease (MCD) is rare in pregnancy with the potential for serious complications including acute kidney injury (AKI)." | 1.40 | Minimal change disease in pregnancy. ( Kerns, E; Lo, JO; Marshall, NE; Rueda, J, 2014) |
| " Rituximab treatment reduces the steroid dosage and the need for immunosuppressive therapy in pediatric patients." | 1.39 | Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease. ( Audard, V; Bouachi, K; Dahan, KY; Deschênes, G; Lang, P; Mojaat, R; Munyentwali, H; Plaisier, EM; Remy, P; Ronco, PM, 2013) |
| "Prednisone treatment significantly normalized the intensities of peaks 9069 and 15005 (which correspond to cortexin-1 and interleukin-17A, respectively, according to Swiss Prot database) by increasing the expression of 9069 but reducing expression of 15005." | 1.39 | Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model. ( Ai, S; Chen, R; Lin, Q; Zheng, J, 2013) |
| " However, the optimal dosing regimen and mechanism of action remain unclear." | 1.39 | Therapy of relapsing minimal-change disease in adults: a new approach? ( Glassock, RJ, 2013) |
| "However, a few cases of minimal change glomerulopathy have been reported in association with systemic lupus erythematosus (SLE)." | 1.37 | A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus. ( Hong, YH; Jung, YW; Kim, HJ; Lee, CK; Oh, MJ; Yun, DY, 2011) |
| "Herein we report a girl who developed autoimmune thyroiditis insidiously during the course of minimal change nephrotic syndrome." | 1.35 | Autoimmune thyroiditis in a child with steroid-dependent nephrotic syndrome. ( Angjeleska, M; Gucev, Z; Petrusevska, G; Ristoska-Bojkovska, N; Tasic, V, 2009) |
| "Strongyloidiasis is caused by a small intestinal nematode with a complex life cycle." | 1.34 | [Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report]. ( Bono, L; Coglitore, M; Faraci, C; Giordano, S; Infurnari, L; Romano, A; Rotolo, U; Rubino, R; Scarlata, F; Tortorici, C, 2007) |
| "Most patients with minimal change nephrotic syndrome are steroid responsive and tolerate this medication." | 1.33 | Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome. ( Frank, R; Gauthier, B; Novak, I; Trachtman, H; Vento, S; Vergara, M, 2005) |
| "Although nondiabetic nephropathies are common among type 2 diabetic patients, very few cases of minimal change nephrotic syndrome have been reported in diabetic patients." | 1.32 | [Relapsing nephrotic syndrome in a diabetic patient with minimal change]. ( Espejo, B; García Donaire, JA; Gutiérrez Martínez, E; Manzanera, MI; Praga, M; Valentín, MO, 2004) |
| "We describe a patient with minimal change disease who presented with heavy proteinuria and acute renal failure but had no evidence of renal interstitial oedema on biopsy." | 1.32 | Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis. ( Cameron, MA; Moe, OW; Peri, U; Rogers, TE, 2004) |
| "Low-dose cyclosporin(CsA) therapy combined with prednisolone was performed in 10 adult patients with frequently relapsing minimal change nephrotic syndrome(MCNS)." | 1.31 | [Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults]. ( Honda, K; Itabashi, M; Koike, M; Nihei, H; Nitta, K; Suzuki, K; Tsukada, M; Uchida, K; Yumura, W, 2002) |
| "A 35-year-old nephrotic man developed acute renal failure with serum creatinine to 1543 micromol/l after a month of therapy with enalapril." | 1.30 | Acute renal failure with severe tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with enalapril. ( Dzikova, S; Grcevska, L; Grozdanovski, R; Polenaković, M, 1997) |
| "In primary minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS), increased lymphocyte reactivity to renal antigens has been defined." | 1.30 | Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response. ( Ahn, SJ; Bang, BK; Chang, YS; Choi, EJ; Kim, SY; Kim, YS; Park, CW; Shin, YS; Song, HC, 1998) |
| "The association of primary sclerosing cholangitis and renal disease is not frequent, and is limited to a few reported cases of immune complex glomerulonephritis." | 1.30 | Minimal change nephropathy presenting in a patient with primary sclerosing cholangitis. ( Fracchia, M; Galatola, G; Manganaro, M; Pera, A; Poccardi, G, 1997) |
| "A patient with sarcoidosis developed minimal change disease presenting as the nephrotic syndrome." | 1.30 | Sarcoid-associated minimal change disease: a case report. ( Cochrane, J; Healy, GF; North-Coombes, JD, 1998) |
| "Treatment with prednisone and vitamin E resulted in complete resolution of the nephrotic syndrome and slow improvement of the yellow nails, respectively." | 1.30 | Yellow nails and minimal change nephrotic syndrome. ( Fernández-Llaca, H; Val-Bernal, JF; Yáñez, S, 1999) |
| " When the glucocorticoid dosage was reduced or the drug discontinued, the nephrotic syndrome recurred." | 1.29 | [T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome]. ( Schollmeyer, P; Späth, M, 1995) |
| "A patient with acute renal failure accompanying nephrotic syndrome associated with minimal change nephropathy acutely reversed with hemodialysis and ultrafiltration." | 1.27 | Renal failure with minimal change nephrotic syndrome: reversal with hemodialysis. ( Bartram, LS; Copley, JB; McMillan, VM; Sjoberg, RJ, 1983) |
| " At the dosage of 2." | 1.27 | Clinical efficacy of levamisole in the treatment of primary nephrosis in children. ( Mongeau, JG; Robitaille, PO; Roy, F, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 79 (49.69) | 18.7374 |
| 1990's | 26 (16.35) | 18.2507 |
| 2000's | 21 (13.21) | 29.6817 |
| 2010's | 25 (15.72) | 24.3611 |
| 2020's | 8 (5.03) | 2.80 |
| Authors | Studies |
|---|---|
| Zotta, F | 1 |
| Vivarelli, M | 4 |
| Carsetti, R | 1 |
| Cascioli, S | 1 |
| Emma, F | 4 |
| Colucci, M | 1 |
| Marampudi, S | 1 |
| Beshai, R | 1 |
| Banker, G | 1 |
| Długosz, G | 1 |
| Masajtis-Zagajewska, A | 1 |
| Nowicki, M | 1 |
| Lucchetti, L | 3 |
| Gatto, A | 3 |
| Gianviti, A | 3 |
| Massella, L | 3 |
| Zhang, J | 1 |
| Zhao, H | 1 |
| Li, X | 2 |
| Qian, R | 1 |
| Gao, P | 1 |
| Lu, S | 1 |
| Ma, Z | 1 |
| Yin, J | 1 |
| Li, Z | 1 |
| Hao, Z | 1 |
| Yu, Z | 1 |
| Yu, W | 1 |
| Yang, G | 1 |
| Ren, X | 1 |
| Lebedev, L | 1 |
| Sapojnikov, M | 1 |
| Wechsler, A | 1 |
| Varadi-Levi, R | 1 |
| Zamir, D | 1 |
| Tobar, A | 1 |
| Levin-Iaina, N | 1 |
| Fytlovich, S | 1 |
| Yagil, Y | 1 |
| Garofalo, C | 1 |
| De Stefano, F | 1 |
| Gjeloshi, K | 1 |
| De Gregorio, I | 1 |
| Masini, F | 1 |
| Ricozzi, C | 1 |
| Sasso, FC | 1 |
| Sica, A | 1 |
| Selvaggi, L | 1 |
| Salvatore, T | 1 |
| Ozeki, T | 1 |
| Katsuno, T | 1 |
| Hayashi, H | 1 |
| Kato, S | 1 |
| Yasuda, Y | 1 |
| Ando, M | 1 |
| Tsuboi, N | 1 |
| Hagiwara, D | 1 |
| Arima, H | 1 |
| Maruyama, S | 1 |
| Korbet, SM | 2 |
| Whittier, WL | 1 |
| Glassock, RJ | 2 |
| Song, M | 1 |
| Li, A | 1 |
| Gong, J | 1 |
| Yang, D | 1 |
| Ma, L | 1 |
| Zhou, X | 1 |
| Yan, Y | 1 |
| Xie, Y | 1 |
| Ishimoto, T | 1 |
| Cara-Fuentes, G | 1 |
| Wang, H | 2 |
| Shimada, M | 1 |
| Wasserfall, CH | 1 |
| Winter, WE | 1 |
| Rivard, CJ | 1 |
| Araya, CE | 1 |
| Saleem, MA | 1 |
| Mathieson, PW | 1 |
| Johnson, RJ | 1 |
| Garin, EH | 2 |
| Wang, J | 2 |
| Juan, C | 1 |
| Huang, Q | 1 |
| Zeng, C | 2 |
| Liu, Z | 3 |
| Lo, JO | 1 |
| Kerns, E | 1 |
| Rueda, J | 1 |
| Marshall, NE | 1 |
| Guo, J | 1 |
| Zou, Y | 1 |
| Wu, Z | 1 |
| Wu, W | 1 |
| Xu, Z | 1 |
| Hu, H | 1 |
| Huang, L | 1 |
| Dong, H | 1 |
| Chen, J | 3 |
| Lu, J | 1 |
| Fu, Y | 1 |
| Ma, Y | 1 |
| Chen, X | 1 |
| He, F | 1 |
| Yang, S | 1 |
| Liao, L | 1 |
| Zheng, F | 1 |
| Tan, J | 1 |
| Eun Kim, J | 1 |
| Il Shin, J | 1 |
| Khow, KS | 1 |
| Yong, AS | 1 |
| Yong, TY | 1 |
| Kuss, BJ | 1 |
| Barbara, JA | 1 |
| Li, JY | 1 |
| Fervenza, FC | 1 |
| Perazella, MA | 1 |
| Choi, MJ | 1 |
| Rood, IM | 1 |
| Hofstra, JM | 2 |
| Deegens, JK | 2 |
| Wetzels, JF | 3 |
| Li, F | 1 |
| Zheng, C | 1 |
| Zhong, Y | 1 |
| Xu, F | 1 |
| Yin, R | 1 |
| Jiang, Q | 1 |
| Zhou, M | 1 |
| Dekkers, MJ | 1 |
| Groothoff, JW | 1 |
| Zietse, R | 1 |
| Betjes, MG | 1 |
| Kurt-Şükür, ED | 1 |
| Özçakar, ZB | 1 |
| Fitöz, S | 1 |
| Yilmaz, S | 1 |
| Teber, S | 1 |
| Ünal İnce, E | 1 |
| Ekim, M | 1 |
| Yalçinkaya, F | 1 |
| Dinçel, N | 1 |
| Yılmaz, E | 1 |
| Kaplan Bulut, İ | 1 |
| Hacıkara, Ş | 1 |
| Mir, S | 1 |
| Wang, DY | 1 |
| Mao, JH | 1 |
| Zhang, Y | 1 |
| Gu, WZ | 1 |
| Zhao, SA | 1 |
| Chen, YF | 1 |
| Liu, AM | 1 |
| Gipson, DS | 1 |
| Massengill, SF | 1 |
| Yao, L | 1 |
| Nagaraj, S | 1 |
| Smoyer, WE | 2 |
| Mahan, JD | 1 |
| Wigfall, D | 1 |
| Miles, P | 1 |
| Powell, L | 1 |
| Lin, JJ | 1 |
| Trachtman, H | 2 |
| Greenbaum, LA | 1 |
| Chugh, SS | 1 |
| Clement, LC | 1 |
| Macé, C | 1 |
| Hong, YH | 1 |
| Yun, DY | 1 |
| Jung, YW | 1 |
| Oh, MJ | 1 |
| Kim, HJ | 1 |
| Lee, CK | 1 |
| Li, H | 2 |
| Shi, X | 1 |
| Shen, H | 1 |
| Xu, G | 1 |
| Redondo-Pachón, MD | 1 |
| Enríquez, R | 1 |
| Sirvent, AE | 1 |
| Andrada, E | 1 |
| Millán, I | 1 |
| Amorós, F | 1 |
| Shahane, A | 1 |
| Khasnis, A | 1 |
| Gota, C | 1 |
| Ai, S | 1 |
| Zheng, J | 1 |
| Lin, Q | 1 |
| Chen, R | 1 |
| Munyentwali, H | 1 |
| Bouachi, K | 1 |
| Audard, V | 1 |
| Remy, P | 1 |
| Lang, P | 1 |
| Mojaat, R | 1 |
| Deschênes, G | 1 |
| Ronco, PM | 1 |
| Plaisier, EM | 1 |
| Dahan, KY | 1 |
| Roncone, D | 1 |
| Rovin, B | 1 |
| Falk, R | 1 |
| Nicely, C | 1 |
| Nadasdy, T | 1 |
| Parikh, S | 1 |
| Hebert, LA | 1 |
| Koike, M | 1 |
| Honda, K | 1 |
| Tsukada, M | 1 |
| Itabashi, M | 1 |
| Suzuki, K | 1 |
| Uchida, K | 1 |
| Nitta, K | 1 |
| Yumura, W | 1 |
| Nihei, H | 1 |
| Stokes, MB | 1 |
| Kwakye, J | 1 |
| D'Agati, VD | 1 |
| LAGRUE, G | 3 |
| LAROCHE, C | 2 |
| MILLIEZ, P | 2 |
| VALLERY-RADOT, P | 2 |
| ROGET, J | 1 |
| BEAUDOING, A | 1 |
| LAGIER, A | 1 |
| FANCONI, G | 1 |
| WIJFFELS, M | 1 |
| HEMPEL-JORGENSEN, P | 1 |
| KOSSOVA, ET | 1 |
| TRAVIS, LB | 1 |
| DODGE, WF | 1 |
| TURNER, RA | 1 |
| SHEARN, MA | 1 |
| TU, WH | 1 |
| PIEL, CF | 1 |
| Niaudet, P | 2 |
| García Donaire, JA | 1 |
| Manzanera, MI | 1 |
| Valentín, MO | 1 |
| Espejo, B | 1 |
| Gutiérrez Martínez, E | 1 |
| Praga, M | 2 |
| Jonkers, IJ | 1 |
| Bruijn, JA | 1 |
| Vleming, LJ | 1 |
| Cameron, MA | 1 |
| Peri, U | 1 |
| Rogers, TE | 1 |
| Moe, OW | 1 |
| Novak, I | 1 |
| Frank, R | 1 |
| Vento, S | 1 |
| Vergara, M | 1 |
| Gauthier, B | 1 |
| Bodaghi, E | 1 |
| Chamsa, AM | 1 |
| Prasad, GV | 1 |
| Vincent, L | 1 |
| Hamilton, R | 1 |
| Lim, K | 1 |
| Gilbert, RD | 1 |
| Hulse, E | 1 |
| Rigden, S | 1 |
| Rotolo, U | 1 |
| Scarlata, F | 1 |
| Giordano, S | 1 |
| Tortorici, C | 1 |
| Bono, L | 1 |
| Coglitore, M | 1 |
| Faraci, C | 1 |
| Infurnari, L | 1 |
| Rubino, R | 1 |
| Romano, A | 1 |
| Yalavarthy, R | 1 |
| Smith, ML | 1 |
| Edelstein, C | 1 |
| Yang, T | 1 |
| Nast, CC | 1 |
| Vo, A | 1 |
| Jordan, SC | 1 |
| Palmer, SC | 1 |
| Nand, K | 1 |
| Strippoli, GF | 1 |
| Tasic, V | 1 |
| Angjeleska, M | 1 |
| Ristoska-Bojkovska, N | 1 |
| Petrusevska, G | 1 |
| Gucev, Z | 1 |
| Soyka, LF | 1 |
| Morawska, Z | 1 |
| Barna, BP | 1 |
| Makker, S | 1 |
| Kallen, R | 1 |
| Valenzuela, R | 1 |
| Deodhar, SD | 1 |
| Yeip, M | 1 |
| Leto, D | 1 |
| Verbic, MA | 1 |
| Rajaraman, S | 1 |
| Govindarajan, S | 1 |
| Barratt, TM | 1 |
| Geary, DF | 1 |
| Ponticelli, C | 3 |
| Banfi, G | 1 |
| Imbasciati, E | 2 |
| Tarantino, A | 1 |
| Cuoghi, D | 1 |
| Vangelista, A | 1 |
| Baraldi, A | 1 |
| Cheli, E | 1 |
| Urdaneta Carruyo, E | 1 |
| Zúñiga Armendariz, V | 1 |
| Gordillo Paniagua, G | 1 |
| Hui, A | 1 |
| Poucell, S | 1 |
| Thorner, P | 1 |
| Rance, CP | 1 |
| Baumal, R | 1 |
| Gómez Campderá, FJ | 1 |
| López Gómez, JM | 1 |
| Cervera, A | 1 |
| Gómez Campderá, J | 1 |
| Canals, MJ | 1 |
| Morales, JL | 1 |
| Luque, A | 1 |
| Tuya, CO | 1 |
| Muñoz, M | 1 |
| Costa, JA | 1 |
| Repetto, HA | 1 |
| Yeung, CK | 1 |
| Wong, KL | 1 |
| Ng, WL | 1 |
| Beale, MG | 1 |
| Nash, GS | 1 |
| Bertovich, MJ | 1 |
| MacDermott, RP | 1 |
| Sjoberg, RJ | 1 |
| McMillan, VM | 1 |
| Bartram, LS | 1 |
| Copley, JB | 1 |
| Wegmüller, E | 1 |
| Papadopoulou, ZL | 1 |
| Jenis, EH | 1 |
| Tina, LU | 1 |
| Novello, AC | 1 |
| Jose, PA | 1 |
| Calcagno, PL | 1 |
| Schoeneman, MJ | 1 |
| McEnery, PT | 1 |
| Strife, CF | 1 |
| Laurent, J | 1 |
| Donadio, JV | 1 |
| Lau, J | 1 |
| Levey, AS | 1 |
| Kassirer, JP | 1 |
| Pauker, SG | 1 |
| Späth, M | 1 |
| Schollmeyer, P | 1 |
| Wang, Z | 1 |
| Atar, S | 1 |
| Oberman, AS | 1 |
| Ben-Izhak, O | 1 |
| Flatau, E | 1 |
| Abouchacra, S | 1 |
| Duguid, WP | 1 |
| Somerville, PJ | 1 |
| Abu-Farsakh, H | 1 |
| Berry, PL | 1 |
| Hill, LL | 1 |
| Powell, D | 1 |
| Hawkins, EP | 1 |
| Gregory, MJ | 1 |
| Sedman, A | 1 |
| Kershaw, DB | 1 |
| Valentini, RP | 1 |
| Johnson, K | 1 |
| Bunchman, TE | 1 |
| Vernace, MA | 1 |
| Bellucci, AG | 1 |
| Mossey, RT | 1 |
| Susin, M | 1 |
| Mailloux, LU | 1 |
| Wilkes, BM | 1 |
| Katz, S | 1 |
| Eskreis, D | 1 |
| Norris, M | 1 |
| Kissel, C | 1 |
| Roy, L | 1 |
| Al-Eisa, A | 1 |
| Carter, JE | 1 |
| Lirenman, DS | 1 |
| Magil, AB | 1 |
| Liss, KA | 1 |
| Gaughan, WJ | 1 |
| McCue, PA | 1 |
| Burke, JF | 1 |
| Grcevska, L | 1 |
| Polenaković, M | 1 |
| Dzikova, S | 1 |
| Grozdanovski, R | 1 |
| Park, CW | 1 |
| Song, HC | 1 |
| Shin, YS | 1 |
| Ahn, SJ | 1 |
| Kim, YS | 1 |
| Kim, SY | 1 |
| Choi, EJ | 1 |
| Chang, YS | 1 |
| Bang, BK | 1 |
| Fracchia, M | 1 |
| Manganaro, M | 1 |
| Poccardi, G | 1 |
| Pera, A | 1 |
| Galatola, G | 1 |
| North-Coombes, JD | 1 |
| Healy, GF | 1 |
| Cochrane, J | 1 |
| Branten, AJ | 1 |
| Yáñez, S | 1 |
| Val-Bernal, JF | 1 |
| Fernández-Llaca, H | 1 |
| Boix, E | 1 |
| Rivera, F | 1 |
| Gil, CM | 1 |
| Pérez-Contreras, J | 1 |
| Olivares, J | 1 |
| Filler, G | 1 |
| Robb, I | 1 |
| Carpenter, B | 1 |
| Matsumoto, K | 1 |
| Kanmatsuse, K | 1 |
| Wang, X | 1 |
| Kallen, RJ | 1 |
| Lee, SK | 1 |
| Moorthy, AV | 1 |
| Zimmerman, SW | 1 |
| Burkholder, PM | 1 |
| Meyrier, A | 2 |
| Simon, P | 1 |
| Knotková, V | 1 |
| Stejkal, J | 1 |
| Stejskalová, A | 1 |
| Tomásek, R | 1 |
| Mendoza, SA | 1 |
| Tune, BM | 1 |
| Nyrop, M | 1 |
| Olgaard, K | 1 |
| Passerini, P | 1 |
| Broyer, M | 1 |
| Habib, R | 1 |
| Condamin, MC | 1 |
| Broneer, D | 1 |
| Brodehl, J | 6 |
| Tejani, A | 1 |
| Suthanthiran, M | 1 |
| Pomrantz, A | 1 |
| Rowe, PC | 1 |
| McLean, RH | 1 |
| Ruley, EJ | 1 |
| Salcedo, JR | 1 |
| Baumgardner, RA | 1 |
| Zaugg, B | 1 |
| Mellits, ED | 1 |
| DeAngelis, C | 1 |
| Martinez, MA | 1 |
| Andres, A | 1 |
| Alvarez de Buergo, M | 1 |
| Bello, I | 1 |
| Millet, VG | 1 |
| Morales, JM | 1 |
| Rotellar, JA | 1 |
| Garcia Ruiz, C | 1 |
| Martinez Vea, A | 1 |
| Carreras Plana, M | 1 |
| Klinger, M | 1 |
| Szewczyk, Z | 1 |
| Warshaw, BL | 1 |
| Hymes, LC | 1 |
| Schneider, K | 1 |
| Hoyer, PF | 3 |
| Krull, F | 1 |
| Andal, A | 1 |
| Saxena, S | 2 |
| Chellani, HK | 1 |
| Sharma, S | 1 |
| Leung, AK | 1 |
| Robson, WL | 1 |
| Jones, DP | 1 |
| Stapleton, FB | 1 |
| Roy, S | 1 |
| Wyatt, RJ | 1 |
| Mongeau, JG | 1 |
| Robitaille, PO | 1 |
| Roy, F | 1 |
| Schwartz, MM | 1 |
| Lewis, EJ | 1 |
| Schulman, SL | 1 |
| Kaiser, BA | 1 |
| Polinsky, MS | 1 |
| Srinivasan, R | 1 |
| Baluarte, HJ | 1 |
| Brandis, M | 1 |
| Helmchen, U | 2 |
| Burghard, R | 1 |
| Ehrich, JH | 1 |
| Zimmerhackl, RB | 1 |
| Klein, W | 1 |
| Wonigeit, K | 1 |
| Koomans, HA | 1 |
| Boer, WH | 1 |
| Dorhout Mees, EJ | 1 |
| Bailey, RR | 1 |
| Lynn, KL | 1 |
| Kashtan, C | 1 |
| Melvin, T | 1 |
| Kim, Y | 1 |
| Shohet, I | 1 |
| Meyerovitch, J | 1 |
| Aladjem, M | 1 |
| Boichis, H | 1 |
| Tiwari, SC | 1 |
| Agarwal, SK | 1 |
| Bajpai, V | 1 |
| Bhuyan, UN | 2 |
| Dash, SC | 1 |
| Malhotra, KK | 1 |
| Peces, R | 1 |
| Riera, JR | 1 |
| López Larrea, C | 1 |
| Alvarez, J | 1 |
| Kühn, K | 1 |
| Koch, KM | 1 |
| Coggins, CH | 1 |
| Gusmano, R | 1 |
| Edefonti, A | 1 |
| Zucchelli, P | 1 |
| Pozzi, C | 1 |
| Grassi, C | 1 |
| Della Volpe, M | 1 |
| Perfumo, F | 1 |
| Petrone, P | 1 |
| Picca, M | 1 |
| Srivastava, RN | 1 |
| Agarwal, RK | 1 |
| Moudgil, A | 1 |
| Polito, C | 1 |
| Oporto, MR | 1 |
| Totino, SF | 1 |
| La Manna, A | 1 |
| Di Toro, R | 1 |
| Cade, R | 1 |
| Mars, D | 1 |
| Privette, M | 1 |
| Thompson, R | 1 |
| Croker, B | 1 |
| Peterson, J | 1 |
| Campbell, K | 1 |
| Shapiro, CM | 1 |
| Vander Laan, BF | 1 |
| Jao, W | 3 |
| Sloan, DE | 1 |
| Sinnassamy, P | 1 |
| O'Regan, S | 1 |
| Pachioli, R | 1 |
| Genova, R | 1 |
| Siegel, NJ | 1 |
| Goldberg, B | 1 |
| Krassner, LS | 1 |
| Hayslett, JP | 2 |
| Lim, VS | 1 |
| Sibley, R | 1 |
| Spargo, B | 1 |
| Lewy, P | 2 |
| Norris, SH | 2 |
| Pollak, VE | 3 |
| Pirani, CL | 3 |
| Kashgarian, M | 1 |
| Bensch, KG | 1 |
| Spargo, BH | 1 |
| Freedman, LR | 1 |
| Epstein, FH | 1 |
| Vajs, D | 1 |
| Bjelica, M | 1 |
| Pandza, Z | 1 |
| Lovrić, E | 1 |
| Chaptal, J | 1 |
| Jean, R | 1 |
| Bonnet, H | 1 |
| Navarro, M | 1 |
| Lloret, R | 1 |
| Ghosh, L | 1 |
| Muehrcke, RC | 2 |
| Derulska, D | 2 |
| Rowecka-Trzebicka, K | 1 |
| Wojnarowski, M | 2 |
| Asamer, H | 1 |
| Dittrich, M | 1 |
| Rosen, S | 1 |
| Kark, RM | 1 |
| Halikowski, B | 1 |
| Kucharska, K | 1 |
| Sancewicz-Pach, K | 1 |
| Manfredi, G | 1 |
| Mei, V | 1 |
| Paolucci, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Effectiveness of Enough Steroids as Inducement Therapy in Minimal Change Disease-like IgA Nephropathy[NCT01451710] | 30 participants (Actual) | Interventional | 2011-03-31 | Completed | |||
| Ofatumumab in Children With Steroid- and Calcineurin-inhibitor-resistant Nephrotic Syndrome: a Double-blind Randomized, Controlled, Superiority Trial[NCT02394106] | Phase 2 | 13 participants (Actual) | Interventional | 2015-07-31 | Terminated | ||
| Ofatumumab Versus Rituximab in Children With Steroid and Calcineurin Inhibitor-dependent Idiopathic Nephrotic Syndrome: an Open-label, Randomized, Controlled, Superiority Trial.[NCT02394119] | Phase 2 | 140 participants (Actual) | Interventional | 2015-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
16 reviews available for prednisone and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
B cell suppression in primary glomerular disease.
Topics: Abatacept; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; B-Lymphocytes; | 2014 |
Kimura disease: a case report and review of the Chinese literature.
Topics: Adolescent; Adult; Angiolymphoid Hyperplasia with Eosinophilia; Biopsy; Child; Child, Preschool; Chi | 2009 |
New insights into human minimal change disease: lessons from animal models.
Topics: Angiopoietin-Like Protein 4; Angiopoietins; Animals; Disease Models, Animal; Glucocorticoids; Humans | 2012 |
Nephrotic syndrome and ARF in a diabetic patient.
Topics: Acute Kidney Injury; Aged; Anti-Inflammatory Agents; Basement Membrane; Biopsy; Comorbidity; Diabete | 2003 |
[Lipoid nephrosis in childhood].
Topics: Adrenal Cortex Hormones; Adult; Age Factors; Anti-Inflammatory Agents; Biopsy; Child; Cyclosporins; | 2003 |
Rapid remission of steroid and mycophenolate mofetil (mmf)-resistant minimal change nephrotic syndrome after rituximab therapy.
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Resistance; Female; Gluc | 2008 |
Interventions for minimal change disease in adults with nephrotic syndrome.
Topics: Adult; Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Methylprednisolone; Nephrosis, Li | 2008 |
Immunosuppressive therapy in primary glomerulonephritis (pros).
Topics: Adrenocorticotropic Hormone; Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulone | 1982 |
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Diuretics; Female; Glomerulonep | 1982 |
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Diuretics; Female; Glomerulonep | 1982 |
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Diuretics; Female; Glomerulonep | 1982 |
Nephrotic syndrome in childhood. Management and treatment in patients with minimal change disease, mesangial proliferation, or focal glomerulosclerosis.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Diuretics; Female; Glomerulonep | 1982 |
Renal cell carcinoma presenting as nephrotic syndrome complicated by acute renal failure.
Topics: Acute Kidney Injury; Aged; Carcinoma, Renal Cell; Cyclophosphamide; Humans; Kidney Neoplasms; Male; | 1993 |
[Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammat | 1998 |
Treatment of the nephrotic syndrome with cyclosporin A.
Topics: Chlorambucil; Cyclophosphamide; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosis, Fo | 1992 |
Conventional treatment of idiopathic nephrotic syndrome and membranous nephropathy in adults.
Topics: Adult; Chlorambucil; Cyclophosphamide; Glomerulonephritis, Membranous; Glomerulosclerosis, Focal Seg | 1991 |
Conventional therapy for idiopathic nephrotic syndrome in children.
Topics: Child; Chlorambucil; Cyclophosphamide; Humans; Nephrosis, Lipoid; Prednisone; Recurrence | 1991 |
The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.
Topics: Alkylating Agents; Child; Chlorambucil; Cyclophosphamide; Cyclosporins; Humans; Immunosuppressive Ag | 1991 |
Lipoid nephrosis: a reassessment.
Topics: Adult; Child; Diagnosis, Differential; Female; Glomerular Mesangium; Humans; Hydrocortisone; Kidney; | 1973 |
16 trials available for prednisone and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
Effects of combined prednisone + fluvastatin on cholesterol and bilirubin in pediatric patients with minimal change nephropathy.
Topics: Bilirubin; Child; Cholesterol; Drug Therapy, Combination; Fatty Acids, Monounsaturated; Female; Fluv | 2013 |
Corticosteroid therapy in IgA nephropathy with minimal change-like lesions: a single-centre cohort study.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Biomarkers; Female; Follow-Up Studies; Glomerular Filtr | 2013 |
Tacrolimus versus intravenous pulse cyclophosphamide therapy in Chinese adults with steroid-resistant idiopathic minimal change nephropathy: a multicenter, open-label, nonrandomized cohort trial.
Topics: Administration, Oral; Adolescent; Adult; China; Cohort Studies; Cyclophosphamide; Drug Therapy, Comb | 2012 |
[Therapeutic trial with levamisole in children with idiopathic minimal change nephrotic syndrome].
Topics: Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Levamisole; Male; Nephrosis, Lipo | 1983 |
Intravenous methylprednisolone pulse therapy in minimal change nephrotic syndrome.
Topics: Adolescent; Adult; Female; Humans; Infusions, Parenteral; Male; Methylprednisolone; Middle Aged; Nep | 1983 |
Long-term cyclosporine therapy for pediatric nephrotic syndrome: a clinical and histologic analysis.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Cyclosporine; Drug Therapy, Combination; Female; Glomer | 1996 |
Treatment of childhood nephrotic syndrome.
Topics: Administration, Oral; Alkylating Agents; Angiotensin-Converting Enzyme Inhibitors; Child; Clinical P | 1992 |
Treatment of adult idiopathic nephrotic syndrome with cyclosporin A: minimal-change disease and focal-segmental glomerulosclerosis. Collaborative Group of the French Society of Nephrology.
Topics: Adult; Cyclosporins; Drug Evaluation; Drug Therapy, Combination; Drug Tolerance; Glomerulosclerosis, | 1991 |
A randomized controlled trial of low-dose prednisone and ciclosporin versus high-dose prednisone in nephrotic syndrome of children.
Topics: Adolescent; Child; Child, Preschool; Cyclosporine; Glomerulonephritis, Membranous; Glomerulosclerosi | 1991 |
The treatment of minimal change nephrotic syndrome: lessons learned from multicentre co-operative studies.
Topics: Alkylating Agents; Child; Chlorambucil; Cyclophosphamide; Cyclosporins; Humans; Immunosuppressive Ag | 1991 |
Intravenous immunoglobulin in minimal change nephrotic syndrome: a crossover trial.
Topics: Adolescent; Child; Child, Preschool; Double-Blind Method; Female; Humans; Immunoglobulins; Infusions | 1990 |
[Programs of immunosuppressive and anti-inflammatory treatment of primary idiopathic glomerulonephritis. I. Submicroscopic and focal segmental glomerulonephritis].
Topics: Adult; Child; Clinical Trials as Topic; Cyclophosphamide; Cyclosporins; Dose-Response Relationship, | 1989 |
[Drug treatment of chronic glomerulonephritis: pro].
Topics: Chlorambucil; Chronic Disease; Clinical Trials as Topic; Cyclophosphamide; Cyclosporins; Glomerulone | 1985 |
Adult minimal change nephropathy: experience of the collaborative study of glomerular disease.
Topics: Adult; Clinical Trials as Topic; Follow-Up Studies; Humans; Kidney Glomerulus; Nephrosis, Lipoid; Pr | 1986 |
Controlled trial of methylprednisolone pulses and low dose oral prednisone for the minimal change nephrotic syndrome.
Topics: Administration, Oral; Adult; Child; Clinical Trials as Topic; Drug Therapy, Combination; Female; Hum | 1985 |
[Importance of chloraminophen in certain nephrotic syndromes].
Topics: Adult; Child; Child, Preschool; Clinical Trials as Topic; Humans; Mechlorethamine; Nephrosis, Lipoid | 1965 |
128 other studies available for prednisone and Glomerulonephritis, Minimal Change
| Article | Year |
|---|---|
Circulating plasmablasts in children with steroid-sensitive nephrotic syndrome.
Topics: Child; Female; Humans; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Plasma Cells; Prednisone; Retros | 2022 |
Reactivation of minimal change disease after Pfizer vaccine against COVID-19.
Topics: COVID-19 Drug Treatment; COVID-19 Vaccines; Edema; Female; Humans; Influenza Vaccines; Middle Aged; | 2022 |
[Efficacy of rituximab in minimal change disease, an atypical renal manifestation of antiphospholipid syndrome].
Topics: Adult; Antibodies, Antiphospholipid; Antibodies, Monoclonal; Anticoagulants; Antiphospholipid Syndro | 2022 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Treatment of idiopathic nephrotic syndrome at onset: a comparison between 8- and 12-week regimens in everyday clinical practice.
Topics: Child; Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Recurrence; Retrospective Studies | 2023 |
Efficacy of low-dose rituximab in minimal change disease and prevention of relapse.
Topics: Adult; Child; Humans; Immunosuppressive Agents; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; R | 2023 |
Minimal change disease with papillary thyroid carcinoma: a report of two adult cases.
Topics: Adult; Female; Humans; Male; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Thyroid | 2023 |
Minimal Change Disease Following the Pfizer-BioNTech COVID-19 Vaccine.
Topics: Acute Kidney Injury; Biopsy; BNT162 Vaccine; COVID-19; COVID-19 Vaccines; Creatinine; Edema; Glucoco | 2021 |
Very large abscesses of lower limbs by Nocardia farcinica requiring surgical management in patient with minimal change disease under chronic steroid treatment.
Topics: Abscess; Aged; Glucocorticoids; Humans; Lower Extremity; Male; Nephrosis, Lipoid; Nocardia; Nocardia | 2021 |
Short-Term Steroid Regimen for Adult Steroid-Sensitive Minimal Change Disease.
Topics: Adult; Biopsy; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Glucocorticoi | 2019 |
Management of Adult Minimal Change Disease.
Topics: Anti-Inflammatory Agents; Humans; Immunosuppressive Agents; Male; Middle Aged; Nephrosis, Lipoid; Ne | 2019 |
Therapy of relapsing minimal-change disease in adults: a new approach?
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Female; Humans; Male; Nephrosis, Lipoid; Pre | 2013 |
Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes.
Topics: Adolescent; Anti-Inflammatory Agents; B7-1 Antigen; Blotting, Western; Cells, Cultured; Child; Child | 2013 |
Minimal change disease in pregnancy.
Topics: Adult; Female; Humans; Kidney; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; Pregnancy; Pregnan | 2014 |
Protective effects of mesenchymal stromal cells on adriamycin-induced minimal change nephrotic syndrome in rats and possible mechanisms.
Topics: Animals; Chemokine CCL2; Doxorubicin; Gene Expression Regulation; Humans; Kidney; Mesenchymal Stem C | 2014 |
Could interleukin-17 be a therapeutic target of steroid-dependent minimal change disease?
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Female; Humans; Male; Nephrosis, Lipoid; Pre | 2013 |
The author replies.
Topics: Antibodies, Monoclonal, Murine-Derived; Antigens, CD20; Female; Humans; Male; Nephrosis, Lipoid; Pre | 2013 |
Minimal change disease associated with newly diagnosed mantle cell lymphoma.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; D | 2014 |
American Society of Nephrology quiz and questionnaire 2013: glomerulonephritis.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antibodies, Monoclonal, Mur | 2014 |
Relationship between serum soluble urokinase plasminogen activator receptor level and steroid responsiveness in FSGS.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Area Under Curve; Biomarkers; Female; Follow-Up Studies | 2014 |
A series of patients with minimal change nephropathy treated with rituximab during adolescence and adulthood.
Topics: Adolescent; Adult; Drug Administration Schedule; Female; Humans; Immunologic Factors; Immunosuppress | 2015 |
Two children with steroid-responsive nephrotic syndrome complicated by cerebral venous sinus thrombosis.
Topics: Adult; Anticoagulants; Child, Preschool; Cyclosporine; Early Diagnosis; Heparin; Heparin, Low-Molecu | 2015 |
The long-term outlook to final outcome and steroid treatment results in children with idiopathic nephrotic syndrome.
Topics: Biopsy; Cyclophosphamide; Disease Progression; Drug Therapy, Combination; Female; Follow-Up Studies; | 2015 |
Management of childhood onset nephrotic syndrome.
Topics: Antineoplastic Agents; Biopsy; Child; Combined Modality Therapy; Cyclophosphamide; Cyclosporine; Dos | 2009 |
A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.
Topics: Antirheumatic Agents; Female; Glucocorticoids; Humans; Hydroxychloroquine; Immunosuppressive Agents; | 2011 |
Minimal-change nephropathy in systemic lupus erythematosus.
Topics: Anti-Inflammatory Agents; Diagnosis, Differential; Edema; Female; Humans; Hypertension, Renal; Immun | 2012 |
Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus.
Topics: Adolescent; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Diuretics; Drug Therapy, C | 2012 |
Proteomic analysis indicates altered expression of plasma proteins in a rat nephropathy model.
Topics: Animals; Biomarkers; Blood Proteins; Databases, Protein; Disease Models, Animal; Doxorubicin; Glucoc | 2013 |
Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease.
Topics: Adolescent; Adult; Aged; Antibodies, Monoclonal, Murine-Derived; Antigens, CD19; Antigens, CD20; Fem | 2013 |
Unexplained severe acute kidney injury with rapid recovery of kidney function 11 months later after the start of high-dose steroid therapy.
Topics: Biopsy; Glomerulosclerosis, Focal Segmental; Glucocorticoids; Humans; Kidney Function Tests; Male; M | 2014 |
[Low-dose cyclosporin therapy combined with prednisolone for relapsing minimal change nephrotic syndrome in adults].
Topics: Adult; Anti-Inflammatory Agents; Cyclosporine; Dose-Response Relationship, Drug; Drug Administration | 2002 |
[Delta-cortisone treatment of lipoid nephrosis; value of prolonged hormone therapy].
Topics: Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1956 |
[Delta-cortisone treatment of lipoid nephrosis; value of prolonged hormone therapy].
Topics: Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1956 |
[Delta-cortisone treatment of lipoid nephrosis; value of prolonged hormone therapy].
Topics: Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1956 |
[Delta-cortisone treatment of lipoid nephrosis; value of prolonged hormone therapy].
Topics: Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1956 |
[Hormonal treatment of lipoid nephrosis; hospital statistics].
Topics: Adrenocorticotropic Hormone; Biometry; Child; Cortisone; Hospitals; Humans; Infant; Nephrosis, Lipoi | 1957 |
[The present state of therapy of lipoid nephrosis].
Topics: Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1958 |
[Effect of epidemic parotitis & prednisone in lipoid nephrosis].
Topics: Humans; Mumps; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1958 |
[Lipoid nephrosis; directives for steroid treatment based on a case with six recurrences; variations in blood complement & 17-ketosteroid excretion].
Topics: 17-Ketosteroids; Child; Hormones; Humans; Infant; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone; | 1959 |
[APROPOS OF THE DYNAMICS OF BLOOD PROTEIN FRACTIONS DURING CORTICOSTEROID THERAPY OF CHILDREN WITH THE NEPHROTIC SYNDROME].
Topics: Blood Protein Electrophoresis; Blood Proteins; Child; Cortisone; Dexamethasone; Humans; Nephrosis; N | 1963 |
THE IDIOPATHIC NEPHROTIC SYNDROME: PATHOPHYSIOLOGY AND TREATMENT.
Topics: Adrenal Cortex Hormones; Blood Proteins; Child; Diuresis; Electrons; Electrophoresis; Humans; Micros | 1964 |
RECURRENT NEPHROTIC SYNDROME.
Topics: Adolescent; Biopsy; Cholesterol; Electrons; Humans; Microscopy; Microscopy, Electron; Nephrosis; Nep | 1964 |
[Relapsing nephrotic syndrome in a diabetic patient with minimal change].
Topics: Chlorambucil; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diagnosis, Differential; Drug Thera | 2004 |
A case of minimal change disease evolving into steroid-dependent nephrotic syndrome with hematuria.
Topics: Adult; Biopsy; Female; Glucocorticoids; Hematuria; Humans; Immunoglobulin A; Nephrosis, Lipoid; Neph | 2004 |
Minimal change disease with acute renal failure: a case against the nephrosarca hypothesis.
Topics: Acute Kidney Injury; Edema; Glomerular Filtration Rate; Glucocorticoids; Hemodiafiltration; Humans; | 2004 |
Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndrome.
Topics: Adolescent; Adrenal Cortex Hormones; Child; Child, Preschool; Female; Humans; Immunosuppressive Agen | 2005 |
[Primary nephrotic syndromes in children in Iran].
Topics: Adolescent; Anti-Inflammatory Agents; Biopsy; Child; Child, Preschool; Chlorambucil; Cyclophosphamid | 1978 |
Minimal change disease in association with fire coral (Millepora species) exposure.
Topics: Acute Kidney Injury; Animals; Anthozoa; Barbados; Bites and Stings; Combined Modality Therapy; Divin | 2006 |
Rituximab therapy for steroid-dependent minimal change nephrotic syndrome.
Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Female; Humans; Infant; Nephrosis, L | 2006 |
Rituximab: effective treatment for severe steroid-dependent minimal change nephrotic syndrome?
Topics: Adult; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Drug Therapy, Combination; Fe | 2007 |
[Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report].
Topics: Adult; Albendazole; Animals; Anthelmintics; Anti-Bacterial Agents; Bacteremia; Ecuador; Endemic Dise | 2007 |
Acute kidney injury complicating minimal change disease: the case for careful use of diuretics and angiotensin-converting enzyme inhibitors.
Topics: Acute Kidney Injury; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Furosemide; Glucocorticoid | 2007 |
Autoimmune thyroiditis in a child with steroid-dependent nephrotic syndrome.
Topics: Adjuvants, Immunologic; Autoantibodies; Child; Child, Preschool; Dose-Response Relationship, Drug; D | 2009 |
Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen.
Topics: Adolescent; Child; Child, Preschool; Female; Glomerulonephritis; Humans; Hydrocortisone; Male; Nephr | 1967 |
[Effect of glycocorticoids on the clinical course of lipoid nephrosis in children].
Topics: Child; Diuresis; Humans; Nephrosis, Lipoid; Prednisone; Water-Electrolyte Balance | 1967 |
A lymphocytotoxic factor(s) in plasma of patients with minimal change nephrotic syndrome: partial characterization.
Topics: Adolescent; Adult; Aged; alpha-Macroglobulins; Child; Child, Preschool; Humans; Immunoglobulin G; Ly | 1983 |
Steroids in renal disease.
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Glomerulonephritis; Glomerulosclerosis, Focal | 1982 |
Relapse of nephrotic syndrome following remission for 20 years.
Topics: Adrenocorticotropic Hormone; Adult; Child, Preschool; Diagnosis, Differential; Glomerulonephritis; G | 1983 |
Clinical features and glomerular immunofluorescence of renal biopsies from children with nephrotic syndrome due to minimal change disease and two variants of mesangial proliferative glomerulonephritis.
Topics: Adolescent; Child; Child, Preschool; Complement System Proteins; Female; Fluorescent Antibody Techni | 1984 |
[Effect of mechlorethamine in idiopathic nephrotic syndrome in childhood].
Topics: Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Drug Tolerance; Female; Glomerulosclerosis, | 1984 |
[Primary corticosteroid-resistant nephrotic syndrome in pediatrics].
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Female; Humans; Immunosuppression Therapy; In | 1984 |
Immunoglobulin synthesis by peripheral blood mononuclear cells in minimal change nephrotic syndrome.
Topics: Adolescent; Adult; B-Lymphocytes; Cells, Cultured; Child; Child, Preschool; Female; Humans; Immunogl | 1983 |
Renal failure with minimal change nephrotic syndrome: reversal with hemodialysis.
Topics: Acute Kidney Injury; Aged; Female; Humans; Nephrosis, Lipoid; Prednisone; Renal Dialysis; Ultrafiltr | 1983 |
Minimal change nephrotic syndrome in children: deaths during the first 5 to 15 years' observation. Report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Bacterial Infections; Child; Child, Preschool; Drug Resistance; Female; Humans; Infant; | 1984 |
[Current therapy of nephrotic syndrome].
Topics: Anticoagulants; Combined Modality Therapy; Diet, Sodium-Restricted; Diuretics; Glomerulonephritis; H | 1984 |
Chronic relapsing minimal change nephrotic syndrome with or without mesangial deposits: long term follow-up.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Female; Fluorescent Antibody Technique; Follow-Up Studi | 1982 |
Minimal change nephrotic syndrome: treatment with low doses of hydrocortisone.
Topics: Adrenal Glands; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Hydrocortisone; M | 1983 |
[Nephrotic syndrome and hypersensitivity to pollens (author's transl)].
Topics: Adult; Humans; Hypersensitivity; Male; Nephrosis, Lipoid; Nephrotic Syndrome; Pollen; Prednisone; Pr | 1982 |
Primary glomerular disease: to treat or not to treat.
Topics: Azathioprine; Chlorambucil; Cyclophosphamide; Dipyridamole; Glomerulonephritis; Glomerulosclerosis, | 1982 |
Early identification of frequent relapsers among children with minimal change nephrotic syndrome. A report of the International Study of Kidney Disease in Children.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Female; Humans; Infant; Kidney; Male; Nephrosis, Lipoid | 1982 |
Idiopathic nephrotic syndrome in a 53-year-old woman. Is a kidney biopsy necessary?
Topics: Adolescent; Adult; Bayes Theorem; Biopsy; Female; Glomerulonephritis; Glomerulosclerosis, Focal Segm | 1982 |
[T-cell lymphoma under immunosuppressive treatment in minimal change glomerulopathy with nephrotic syndrome].
Topics: Adult; Chlorambucil; Cyclosporins; Female; Humans; Immunosuppressive Agents; Lymphoma, T-Cell; Nephr | 1995 |
[Changes in rat glomerular polyanion and ultrastructures induced by supernatants of cultured mononuclear cells from patients with steroid-response nephrotic syndrome].
Topics: Animals; Child, Preschool; Culture Media, Conditioned; Female; Humans; Kidney Glomerulus; Leukocytes | 1995 |
Recurrent nephrotic syndrome associated with Kimura's disease in a young non-Oriental male.
Topics: Adult; Angiolymphoid Hyperplasia with Eosinophilia; Humans; Male; Nephrosis, Lipoid; Prednisone; Rec | 1994 |
Mesangial IgG in childhood minimal change disease: clinical relevance.
Topics: Biopsy; Child, Preschool; Chlorambucil; Cyclophosphamide; Cyclosporine; Fluorescent Antibody Techniq | 1993 |
Minimal change nephropathy associated with sclerosing mesenteritis.
Topics: Aged; Anti-Inflammatory Agents; Cachexia; Fat Necrosis; Humans; Kidney Glomerulus; Male; Mesentery; | 1996 |
Minimal change glomerulonephritis in a 90-year-old patient: what is the ideal approach?
Topics: Aged; Aged, 80 and over; Anti-Inflammatory Agents; Biopsy; Female; Glomerulonephritis; Humans; Kidne | 1996 |
Childhood IgM nephropathy: comparison with minimal change disease.
Topics: Biopsy; Child; Child, Preschool; Chromium; Female; Glomerular Mesangium; Hematuria; Humans; Hyperten | 1996 |
Coexistence of atheroemboli and minimal-change disease.
Topics: Acute Kidney Injury; Aged; Biopsy, Needle; Embolism, Cholesterol; Glucocorticoids; Humans; Kidney Gl | 1997 |
Acute renal failure with severe tubulointerstitial changes in a patient with minimal change nephrotic syndrome treated with enalapril.
Topics: Acute Kidney Injury; Adult; Cyclophosphamide; Enalapril; Humans; Kidney; Kidney Tubules; Male; Methy | 1997 |
Urinary soluble HLA class I antigen in patients with minimal change disease: a predictor of steroid response.
Topics: Adolescent; Adult; Biopsy; Creatinine; Diagnosis, Differential; Female; Glomerulonephritis, Membrano | 1998 |
Minimal change nephropathy presenting in a patient with primary sclerosing cholangitis.
Topics: Adult; Anti-Inflammatory Agents; Cholangitis, Sclerosing; Humans; Immunity, Cellular; Immunophenotyp | 1997 |
Sarcoid-associated minimal change disease: a case report.
Topics: Adult; Anti-Inflammatory Agents; Female; Glucocorticoids; Humans; Lung Diseases; Nephrosis, Lipoid; | 1998 |
Yellow nails and minimal change nephrotic syndrome.
Topics: Adult; Anti-Inflammatory Agents; Humans; Male; Nail Diseases; Nephrosis, Lipoid; Prednisone; Vitamin | 1999 |
Steroid-responsive nephrotic syndrome with minimal-change disease and IgA deposits in a HIV-infected patient.
Topics: Anti-HIV Agents; Antihypertensive Agents; Calcium Channel Blockers; Glomerular Mesangium; Glucocorti | 2000 |
Macrohematuria with electron-dense deposits in a 14-year-old boy with minimal change nephrotic syndrome.
Topics: Adolescent; Biopsy; Diagnosis, Differential; Glucocorticoids; Hematuria; Humans; Kidney; Male; Nephr | 2001 |
Transforming growth factor-beta1 inhibits vascular permeability factor release by T cells in normal subjects and in patients with minimal-change nephrotic syndrome.
Topics: Adult; Capillary Permeability; Case-Control Studies; Concanavalin A; Dose-Response Relationship, Dru | 2001 |
Shen's experience in application of the drugs for tonifying the kidney to reduce and withdraw adrenocortical hormone.
Topics: Adolescent; Adult; Anti-Inflammatory Agents; Asthma; Drugs, Chinese Herbal; Female; Humans; Male; Mi | 2001 |
A study of the plasma kinin-generating system in children with the minimal lesion, idiopathic nephrotic syndrome.
Topics: alpha-Macroglobulins; Aprotinin; Capillary Permeability; Child; Humans; Kallikreins; Kidney Glomerul | 1975 |
Inhibition of lymphocyte blastogenesis by plasma of patients with minimal-change nephrotic syndrome.
Topics: Adolescent; Adult; Aged; Female; Humans; Immunity, Cellular; Kidney Diseases; Kidney Function Tests; | 1976 |
[Basis of a therapeutic protocol of nephrotic syndrome with minimal glomerular lesions in adults (proceedings)].
Topics: Humans; Kidney Glomerulus; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1978 |
[Lipoid nephrosis and idiopathic membranous glomerulonephritis in aduits. Our observations on its therapy (authros' transl].
Topics: Adult; Female; Glomerulonephritis; Humans; Male; Middle Aged; Nephrosis, Lipoid; Prednisone | 1977 |
[Cyclosporin A treatment of adult patients with severe nephrotic syndrome].
Topics: Adult; Cyclosporine; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nephrosis, Lipoid | 1992 |
Treatment of idiopathic nephrotic syndrome with cyclosporin A in children.
Topics: Child; Cyclosporins; Female; Humans; Kidney; Male; Methylprednisolone; Nephritis, Interstitial; Neph | 1991 |
Acute renal failure and tubular dysfunction associated with minimal change nephrotic syndrome.
Topics: Acute Kidney Injury; Administration, Oral; Adult; Female; Follow-Up Studies; Humans; Kidney Tubules; | 1989 |
Minimal-change glomerulopathy associated with diclofenac: response to prednisone.
Topics: Diclofenac; Humans; Male; Middle Aged; Nephrosis, Lipoid; Prednisone | 1989 |
Daily single-dose and daily reduced-dose prednisone therapy for children with the nephrotic syndrome.
Topics: Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Nephrosis, | 1989 |
Effect of prednisone on nephrotic peripheral blood mononuclear cell mediated increase in 35sulfate uptake in rat glomerular basement membrane.
Topics: Adolescent; Adult; Animals; Basement Membrane; Biological Assay; Cells, Cultured; Child; Child, Pres | 1989 |
[A case from practice (148). 1. Hodgkin disease, nodular sclerosing, Stage Ia. 2. Status following minimal-change glomerulonephritis with nephrotic syndrome 1980--status following endoxan and prednisone therapy].
Topics: Adult; Cyclophosphamide; Diagnosis, Differential; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; | 1989 |
Cyclosporin in frequently relapsing minimal change nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclosporins; Drug Evaluation; Drug Therapy, Combination; Femal | 1986 |
Pure mesangial proliferative glomerulonephritis. A clinicomorphologic analysis and its possible role in morphologic transition of minimal change lesion.
Topics: Adolescent; Child; Child, Preschool; Glomerulonephritis, Membranoproliferative; Glomerulosclerosis, | 1989 |
Ciclosporin in idiopathic nephrotic syndrome of children.
Topics: Child; Cyclosporins; Female; Glomerulonephritis; Glomerulosclerosis, Focal Segmental; Humans; Male; | 1989 |
Parent-child minimal change nephrotic syndrome.
Topics: Child, Preschool; Female; Humans; Male; Nephrosis, Lipoid; Prednisone | 1989 |
Beneficial effect of second courses of cytotoxic therapy in children with minimal change nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Drug Resistance; Female; Humans | 1988 |
Clinical efficacy of levamisole in the treatment of primary nephrosis in children.
Topics: Adolescent; Child; Child, Preschool; Clinical Trials as Topic; Female; Humans; Levamisole; Male; Nep | 1988 |
Minimal-change glomerulopathy of adulthood.
Topics: Adult; Female; Humans; Male; Middle Aged; Nephrosis, Lipoid; Prednisone; Remission, Spontaneous; Ste | 1988 |
Predicting the response to cytotoxic therapy for childhood nephrotic syndrome: superiority of response to corticosteroid therapy over histopathologic patterns.
Topics: Adolescent; Biopsy; Child; Child, Preschool; Chlorambucil; Cyclophosphamide; Glomerulonephritis; Glo | 1988 |
Cyclosporin A treatment in children with minimal change nephrotic syndrome and focal segmental glomerulosclerosis.
Topics: Biopsy; Child; Cyclosporins; Drug Therapy, Combination; Female; Follow-Up Studies; Glomerulonephriti | 1988 |
Renal function during recovery from minimal lesions nephrotic syndrome.
Topics: Adolescent; Adult; Blood Proteins; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Kidney; | 1987 |
Steroid-responsive nephrotic syndrome due to minimal change nephropathy occurring while on captopril.
Topics: Captopril; Female; Humans; Middle Aged; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1987 |
Long-term follow-up of patients with steroid-dependent, minimal change nephrotic syndrome.
Topics: Adolescent; Adult; Chlorambucil; Cyclophosphamide; Follow-Up Studies; Growth; Humans; Nephrosis, Lip | 1988 |
Cyclophosphamide in treatment of minimal change nephrotic syndrome.
Topics: Adolescent; Child; Child, Preschool; Cyclophosphamide; Drug Administration Schedule; Drug Therapy, C | 1988 |
Idiopathic adult minimal change disease. A clinicopathological study and response to therapy.
Topics: Adult; Cyclophosphamide; Female; Humans; Kidney; Male; Nephrosis, Lipoid; Prednisone | 1987 |
Steroid-responsive relapsing nephrotic syndrome associated with early diabetic glomerulopathy in a child.
Topics: Child; Cyclophosphamide; Diabetic Nephropathies; Humans; Male; Nephrosis, Lipoid; Nephrotic Syndrome | 1987 |
Late resistance to corticosteroids in nephrotic syndrome.
Topics: Adrenal Cortex Hormones; Child; Child, Preschool; Cyclophosphamide; Drug Resistance; Drug Therapy, C | 1986 |
Normal growth of nephrotic children during long-term alternate-day prednisone therapy.
Topics: Bone Development; Child; Child, Preschool; Drug Administration Schedule; Female; Follow-Up Studies; | 1986 |
Effect of long-term azathioprine administration in adults with minimal-change glomerulonephritis and nephrotic syndrome resistant to corticosteroids.
Topics: Adolescent; Adult; Aged; Azathioprine; Child; Child, Preschool; Creatinine; Drug Resistance; Female; | 1986 |
Nephrotic syndrome in two patients with cured Hodgkin's disease.
Topics: Adult; Chlorambucil; Gallium Radioisotopes; Hodgkin Disease; Humans; Male; Nephrosis, Lipoid; Nephro | 1985 |
Mesangial IgA deposits with steroid responsive nephrotic syndrome: probable minimal lesion nephrosis.
Topics: Biopsy; Child; Child, Preschool; Diagnosis, Differential; Glomerular Mesangium; Glomerulonephritis, | 1985 |
Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome.
Topics: Adrenocorticotropic Hormone; Azathioprine; Child; Chronic Disease; Cyclophosphamide; Glomerulonephri | 1971 |
Long-term follow-up of children with steroid-responsive nephrotic syndrome.
Topics: Adrenocorticotropic Hormone; Blood Urea Nitrogen; Child; Child, Preschool; Creatinine; Female; Follo | 1972 |
Adult lipoid nephrosis: clinicopathological correlations.
Topics: Adolescent; Adrenocorticotropic Hormone; Adult; Age Factors; Biopsy; Female; Fluorescent Antibody Te | 1974 |
Clinicopathological correlations in the nephrotic syndrome due to primary renal disease.
Topics: Acute Disease; Adolescent; Adult; Aged; Autopsy; Azathioprine; Biopsy; Child; Child, Preschool; Chro | 1973 |
Lipoid nephrosis: an approach to the clinicopathologic analysis and dismemberment of idiopathic nephrotic syndrome with minimal glomerular changes.
Topics: Biopsy; Blood Urea Nitrogen; Creatinine; Humans; Kidney Glomerulus; Microscopy, Electron; Nephrosis, | 1973 |
[Nephrosis, corticosteroid therapy and varicella].
Topics: Chickenpox; Child, Preschool; Cushing Syndrome; Female; Humans; Nephrosis, Lipoid; Prednisone | 1974 |
Nephrotic syndrome: a prodrome to lymphoma.
Topics: Adolescent; Aged; Biopsy; Hodgkin Disease; Humans; Kidney; Lymphoma, Non-Hodgkin; Male; Microscopy, | 1970 |
[Corticoid therapy of lipoid nephrosis in children].
Topics: Child; Humans; Nephrosis, Lipoid; Prednisone; Time Factors | 1970 |
The fate of children with nephrotic syndrome in the light of the author's material.
Topics: Anti-Bacterial Agents; Child; Child, Preschool; Female; Follow-Up Studies; Glucocorticoids; Humans; | 1970 |
QImmunosuppressive therapy of glomerulonephritis.
Topics: Azathioprine; Biopsy; Glomerulonephritis; Humans; Immunosuppressive Agents; Methotrexate; Nephrosis, | 1970 |
Natural history of lipoid nephrosis and of membranous glomerulonephritis.
Topics: Adolescent; Adult; Aged; Basement Membrane; Biopsy; Body Weight; Child; Child, Preschool; Cholestero | 1968 |
[Results of immunosuppressive treatment in kidney diseases in children].
Topics: Adolescent; Child; Child, Preschool; Female; Humans; Kidney Diseases; Male; Mercaptopurine; Nephrosi | 1969 |
[Considerations on the fate of nephrotics treated with modern therapeutic means (observations on 10 years of case reports of the Pediatric Clinic)].
Topics: Humans; Nephrosis, Lipoid; Nephrotic Syndrome; Prednisone | 1965 |